I agree that this site is using cookies. You can find further informations here.
X
Veluswamy, Rajwanth R.
33  results:
Search for persons X
?
1

Outcomes Following SBRT vs. IMRT and 3DCRT for Older Patien..:

Tran, Jessica H. ; Mhango, Grace ; Park, Henry S....
Clinical Lung Cancer.  24 (2023)  1 - p. e9-e18 , 2023
Link: https://doi.org/10.1016/..
 
?
2

The global burden of lung cancer: current status and future..:

Leiter, Amanda ; Veluswamy, Rajwanth R. ; Wisnivesky, Juan P.
Nature Reviews Clinical Oncology.  20 (2023)  9 - p. 624-639 , 2023
Link: https://doi.org/10.1038/..
 
?
3

The benefits and harms of adjuvant chemotherapy for non-sma..:

Leiter, Amanda ; Kong, Chung Yin ; Gould, Michael K....
PLOS ONE.  17 (2022)  11 - p. e0263911 , 2022
Link: https://doi.org/10.1371/..
 
?
4

Modulation of chemoimmunotherapy efficacy in non-small cell..:

Tuminello, Stephanie ; Alpert, Naomi ; Veluswamy, Rajwanth R....
BMC Cancer.  22 (2022)  1 - p. , 2022
Link: https://doi.org/10.1186/..
 
?
5

Post-anticoagulant D-dimer is a highly prognostic biomarker..:

Song, Xiaoyu ; Ji, Jiayi ; Reva, Boris...
ERJ Open Research.  , 2021
Link: https://doi.org/10.1183/..
 
?
6

3363 Prognostic Value of Immune-Related Biomarkers in Resec..:

Veluswamy, Rajwanth R ; Tuminello, Stephanie ; Petralia, Francesca...
Journal of Clinical and Translational Science.  3 (2019)  s1 - p. 153-153 , 2019
Link: https://doi.org/10.1017/..
 
?
7

Benefits and Challenges of Lung Cancer Screening in Older A..:

Fabrikant, Meytal S. ; Wisnivesky, Juan P. ; Marron, Thomas..
Clinical Therapeutics.  40 (2018)  4 - p. 526-534 , 2018
Link: https://doi.org/10.1016/..
 
?
8

Atypical hemolytic uremic syndrome associated with Capnocyt..:

Sokol, Kelsey A. ; Veluswamy, Rajwanth R. ; Zimmerman, Brittney S...
American Journal of Hematology.  92 (2016)  3 - p. 322-322 , 2016
Link: https://doi.org/10.1002/..
 
?
9

Outcomes Following SBRT vs. IMRT and 3DCRT for Older Patien..:

Tran, Jessica H ; Mhango, Grace ; Park, Henry S...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10332852/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
10

Modulation of chemoimmunotherapy efficacy in non-small cell..:

Tuminello, Stephanie ; Alpert, Naomi ; Veluswamy, Rajwanth R...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767728/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
11

Adverse Events Following Limited Resection versus Stereotac..:

Wang, Qian ; Stone, Kimberly ; Kern, Jeffrey A...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743482/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
12

Post-anticoagulant D-dimer is a highly prognostic biomarker..:

Song, Xiaoyu ; Ji, Jiayi ; Reva, Boris...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7942219/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
13

Proteogenomic characterization reveals therapeutic vulnerab..:

Gillette, Michael A ; Satpathy, Shankha ; Cao, Song...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373300/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
14

3363 Prognostic Value of Immune-Related Biomarkers in Resec..:

Veluswamy, Rajwanth R ; Tuminello, Stephanie ; Petralia, Francesca...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798428/.  , 2019
Link: http://www.ncbi.nlm.nih...
 
?
15

Outcomes following Stereotactic Body Radiotherapy vs. Limit..:

Ezer, Nicole ; Veluswamy, Rajwanth R ; Mhango, Grace...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4511922/.  , 2015
Link: http://www.ncbi.nlm.nih...
 
1-15